海洋药物和生物制品业加快创新。2024年实现增加值190.5亿元。"蓝色药库"开发迈向新阶段,海洋一类 新药BG136完成I期临床试验,抗乙肝病毒海洋药物LY102获批临床准入。海洋药物制造创新发展,逢时科 技发布中国首款双功能蓝帽磷虾油,挖掘南极磷虾油在药用方面的价值。 海洋新兴产业作为构建现代化海洋产业体系的关键要素,具有高技术引领性和创新驱动性,为海洋经济发 展注入活力。近年来,山东以海洋工程装备制造业、海洋药物和生物制品业、海洋电力业、海水淡化与 综合利用业为代表的海洋新兴产业不断培育壮大。2018年以来,全省海洋新兴产业增加值累计增长 64.8%,平均增速达8.7%,高于海洋产业平均增速2.8个百分点,海洋新兴产业已成为全省海洋经济高质量发 展重要引擎。2024年,4个海洋新兴产业实现增加值558.6亿元,同比增长7.3%,高于主要海洋产业平均增速 0.4个百分点。 海洋工程装备制造业迭代升级。2024年实现增加值170.1亿元,比上年增长10.5%。 海洋电力业绿色低碳发展良好。2024年实现增加值151.3亿元,比上年增长10.7%。产能规模稳步提升,截 至2024年底,全省海上风电累计总装机规 ...

Core Viewpoint - Shandong's marine economy is becoming a significant driver of high-quality development, with a projected marine production value exceeding 1.8 trillion yuan in 2024, accounting for 18.3% of the province's GDP [1] Group 1: Marine Economy Development - Shandong's marine production value is expected to reach 1.8 trillion yuan in 2024, marking a 6.1% increase from the previous year, contributing 23.9% to the province's economic growth [10] - The province is focusing on integrating land and sea resources, promoting green and low-carbon transformation of traditional marine industries, and fostering innovation in emerging marine industries [7][8] - The establishment of the "National Marine Ranch" and the successful operation of the "Guoxin 1" aquaculture vessel highlight the advancements in marine production capabilities [1][3] Group 2: Technological Innovation - Shandong is enhancing its marine technology capabilities, achieving breakthroughs in deep-sea observation, marine pharmaceuticals, and high-end equipment, which are crucial for the marine economy's high-quality development [2][4] - The "South China Sea Integrated Observation Network" has been operational for over a decade, providing 80% of the national long-term observation data for the South China Sea [2] - The development of marine pharmaceuticals, including the completion of Phase I clinical trials for new drugs, showcases Shandong's commitment to marine biotechnology [3] Group 3: Ecological Restoration - Shandong is integrating ecological restoration into marine development, with successful projects like the large-scale cultivation of eelgrass in Rongcheng, which has improved local biodiversity and increased the population of wintering swans [11][12][13] - The province has invested significantly in marine ecological protection and restoration, with over 41 billion yuan in central funding and 19.73 billion yuan in local investment [14] - Successful coastal restoration projects in Rizhao have transformed polluted areas into beautiful beaches, enhancing both ecological health and tourism potential [13][14]

Core Insights - The "2025 Asia Brand 500" list was released, featuring seven Chinese companies in the top ten, including Huawei and Alibaba, with Fengshi Technology ranking 356th, improving by 23 positions from last year, and its brand value reaching 42.818 billion yuan [1] Group 1: Company Performance - Fengshi Technology has maintained its position as the global leader in krill oil sales for two consecutive years, with its VIK brand being the top-selling domestic brand in China [2] - The company's krill oil products have achieved a 100% pass rate in international quality inspections for five years and are the first to receive ORIVO's "5-year defect-free" certification [2] - The repurchase rate for Fengshi Technology's krill oil products is 40% [2] Group 2: Industry Expansion - Fengshi Technology is expanding its industry footprint by developing multiple "krill+" sectors, including marine technology, biomedicine, and pet technology [2] - The company launched China's first dual-function blue hat krill oil in 2024, contributing to the development of the biomedicine sector for the Antarctic krill industry [2] - A marine medicine research and innovation base was established, focusing on high-end oral formulations for chronic and metabolic diseases, neurodegenerative diseases, and tumors [2] Group 3: Strategic Collaborations - Fengshi Technology initiated a strategic partnership with Norway's Aker to develop lipid-lowering drugs and collaborated with China Pharmaceutical University on marine polypeptide projects for anti-tumor and anti-aging research [3] - The company collaborates with various universities and research institutions to innovate in areas such as krill phospholipid medicinal excipients and marine bioactive substances [5] - Fengshi Technology has established a comprehensive offline channel strategy, aiming to build flagship stores, specialty stores, and counters across China, with over 1,900 stores currently [6] Group 4: Global Outreach - The company has formed partnerships with top global players, including Aker and Italian plant extract leader Indena, to enhance the high-value utilization of Antarctic krill [6] - Fengshi Technology's products are now sold in 22 countries and regions, including the UK, France, Germany, and New Zealand [6] - Collaborations with major companies in the gelatin and pharmaceutical packaging sectors have been established to further enhance its market presence [6]